Target Name: KRT85
NCBI ID: G3891
Review Report on KRT85 Target / Biomarker Content of Review Report on KRT85 Target / Biomarker
KRT85
Other Name(s): Keratin, type II cuticular Hb5 (isoform 1) | hard keratin, type II, 5 | Keratin-85 | K85 | Keratin, type II cuticular Hb5 | Hard keratin, type II, 5 | Type II hair keratin Hb5 | type II hair keratin Hb5 | Hair keratin K2.12 | keratin 85, type II | hair keratin K2.12 | ECTD4 | KRT85 variant 1 | keratin, hair, basic, 5 | KRTHB5 | type-II keratin Kb25 | Keratin, hair, basic, 5 | Type-II keratin Kb25 | keratin 85 | HB5 | Keratin 85, transcript variant 1 | Hb-5 | hHb5 | KRT85_HUMAN

KRT85: Key Component of The Extracellular Matrix and Immune System

KRT85, also known as Keratin Type II Cuticular Hb5 (ISO Form 1), is a protein that is expressed in the skin and hair. It is a key component of the extracellular matrix (ECM), which is a complex tissue that provides support and structure to various body parts. KRT85 is a protein that is composed of 5伪 and 5尾 chains, which are connected by a middle chain.

KRT85 is a protein that is expressed in the skin and hair, and it is a key component of the extracellular matrix (ECM). The ECM is a complex tissue that provides support and structure to various body parts. It is made up of a variety of proteins, including KRT85, which is a key component of the ECM.

KRT85 is a protein that is involved in the formation and maintenance of the ECM. It is one of the proteins that is known as a scaffold protein, which means that it provides structure to the ECM. KRT85 helps to hold the ECM in place and provides it with a framework that allows it to support and protect various body parts.

KRT85 is also involved in the regulation of cell signaling. It is a signaling molecule, which means that it is involved in the transfer of information from cells to other cells. KRT85 helps to regulate the signaling processes that occur between cells, which is important for the development and maintenance of tissues and organs.

KRT85 is also involved in the regulation of inflammation. It is a potent antioxidant, which means that it protects cells from damage caused by free radicals. Free radicals are unstable molecules that can cause inflammation and contribute to the development of various diseases. KRT85 helps to neutralize free radicals and reduce their effects on cells.

KRT85 is also involved in the regulation of the immune system. It is a immune response protein, which means that it is involved in the immune system. KRT85 helps to regulate the activity of immune cells and is involved in the development and maintenance of the immune system.

KRT85 is also involved in the regulation of the skin. It is a key component of the skin, which is the body's largest organ. KRT85 helps to maintain the structure and function of the skin, which is important for the preservation of body heat and the regulation of body moisture.

In conclusion, KRT85 is a protein that is involved in the formation and maintenance of the extracellular matrix, and it is a key component of the immune system, the skin, and the hair. It is also involved in the regulation of cell signaling, inflammation, and the immune system. As a result, KRT85 may be a drug target or biomarker for the development of various diseases. Further research is needed to fully understand the role of KRT85 in the body and its potential as a therapeutic target.

Protein Name: Keratin 85

The "KRT85 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT85 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36 | KRT8P37 | KRT8P39 | KRT8P41 | KRT8P44 | KRT8P45 | KRT8P46 | KRT8P47 | KRT8P48 | KRT8P49 | KRT8P5 | KRT8P7 | KRT8P8 | KRT8P9 | KRT9 | KRT90P | KRTAP1-1 | KRTAP1-3 | KRTAP1-4 | KRTAP1-5 | KRTAP10-1 | KRTAP10-10 | KRTAP10-11 | KRTAP10-12 | KRTAP10-2 | KRTAP10-3 | KRTAP10-4 | KRTAP10-5 | KRTAP10-6 | KRTAP10-7 | KRTAP10-8 | KRTAP10-9 | KRTAP11-1 | KRTAP12-1 | KRTAP12-2 | KRTAP12-3 | KRTAP12-4 | KRTAP13-1 | KRTAP13-2 | KRTAP13-3 | KRTAP13-4 | KRTAP15-1 | KRTAP16-1 | KRTAP17-1 | KRTAP19-1 | KRTAP19-2 | KRTAP19-3 | KRTAP19-4 | KRTAP19-5 | KRTAP19-6 | KRTAP19-7 | KRTAP19-8 | KRTAP2-1 | KRTAP2-2 | KRTAP2-3 | KRTAP2-4 | KRTAP20-1 | KRTAP20-2 | KRTAP20-3 | KRTAP20-4 | KRTAP21-1 | KRTAP21-2 | KRTAP21-3 | KRTAP22-1 | KRTAP22-2 | KRTAP23-1 | KRTAP25-1 | KRTAP26-1 | KRTAP27-1 | KRTAP29-1 | KRTAP3-1 | KRTAP3-2 | KRTAP3-3 | KRTAP4-1 | KRTAP4-11 | KRTAP4-12 | KRTAP4-2 | KRTAP4-3 | KRTAP4-4 | KRTAP4-5 | KRTAP4-6 | KRTAP4-7 | KRTAP4-8